SCHEDULE 13G
Statement of Beneficial Ownership
Vivos Therapeutics, Inc. Filed Acc 0002049575-24-000001
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| V-CO Investors LLC | 514,498 | 9.9% |
| SP Manager LLC | 514,498 | 9.9% |
| Michael Skaff | 514,498 | 9.9% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-09-03 SCHEDULE 13G/A · Streeterville Capital LLC 0.6%
- 2026-08-14 SCHEDULE 13G/A · Armistice Capital, LLC 4.99%
- 2026-08-11 SCHEDULE 13G · Streeterville Capital LLC 9.3%
- 2026-07-15 SCHEDULE 13D · SP Manager LLC 19.9%
- 2026-05-15 SCHEDULE 13G · Armistice Capital, LLC 8.27%
- 2026-04-02 SCHEDULE 13D · SP Manager LLC 19.9%
- 2025-07-14 SCHEDULE 13G · Dawei Luo 8.52%
- 2025-06-16 SCHEDULE 13D · SP Manager LLC 19.9%
- 2024-12-30 SCHEDULE 13G · Mitchell P. Kopin 4.99%
- 2024-12-20 SCHEDULE 13G · V-CO Investors LLC 9.9%
- 2024-11-14 SC 13G/A · Ionic Ventures, LLC 1.8%
- 2024-11-14 SC 13G/A · Armistice Capital, LLC 4.99%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…